LEVONORGESTREL AND ETHINYL ESTRADIOL vs TESTOSTERONE

Compare LEVONORGESTREL AND ETHINYL ESTRADIOL (Hormone) and TESTOSTERONE (Testopel) — clinical data, side effects, and patient experiences.

LEVONORGESTREL AND ETHINYL ESTRADIOL

· Hormone

How it works

12.1 Mechanism of Action COCs prevent pregnancy primarily by suppressing ovulation.

Approved for

a progestin

and ethinyl estradiol

an estrogen

indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )

OralTablet

TESTOSTERONE

Testopel · Hormone

How it works

Other agent

Approved for

bilateral torsion

orchitis

vanishing testes syndrome

or orchiectomy. b. Hypogonadotropic hypogonadism (congenital or acquired) - gonadotropic LHRH deficiency

SubcutaneousTablet

Quick Comparison

LEVONORGESTREL AND ETHINYL ESTRADIOLTESTOSTERONE

Drug Class

Hormone

Route

Oral

Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

LEVONORGESTREL AND ETHINYL ESTRADIOL

Nausea

0.1-1%

Abdominal Pain

0.1-1%

Drug Not Working

0.1-1%

Headache

0.1-1%

TESTOSTERONE

Drug Not Working

>10%

Fatigue

1-10%

Anxiety

1-10%

Weakness

1-10%

Headache

0.1-1%

Nausea

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

LEVONORGESTREL AND ETHINYL ESTRADIOL

5 WARNINGS AND PRECAUTIONS Vascular risks: Stop if a thrombotic or thromboembolic event occurs
Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years
If feasible, stop Iclevia at least 4 weeks before and through 2 weeks after major surgery or other surgeries known to have an elevated risk of thromboembolism
The risk of postpartum thromboembolism decreases after the third postpartum week, whereas the likelihood of ovulation increases after the third postpartum week

TESTOSTERONE

WARNINGS In patients with breast cancer, androgen therapy may cause hypercalcemia by stimulating osteolysis
Peliosis hepatis can be a life-threatening or fatal complication
Men treated with androgens may be at an increased risk for the development of prostatic hypertrophy and prostatic carcinoma
To date, epidemiologic studies and randomized controlled trials have been inconclusive for determining the risk of major adverse cardiovascular events (MACE), such as non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, with the use of testosterone compared to non-use

Clinical Trial Data

No head-to-head clinical studies found for LEVONORGESTREL AND ETHINYL ESTRADIOL vs TESTOSTERONE.

LEVONORGESTREL AND ETHINYL ESTRADIOL vs TESTOSTERONE: What You Should Know

Key Differences

Both LEVONORGESTREL AND ETHINYL ESTRADIOL and TESTOSTERONE belong to the Hormone class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. LEVONORGESTREL AND ETHINYL ESTRADIOL is administered via Oral, whereas TESTOSTERONE uses Subcutaneous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

LEVONORGESTREL AND ETHINYL ESTRADIOL carries 4 FDA warnings. TESTOSTERONE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

LEVONORGESTREL AND ETHINYL ESTRADIOL vs NORGESTIMATE AND ETHINYL ESTRADIOL→ESTRADIOL VALERATE AND ESTRADIOL VALERATE vs LEVONORGESTREL AND ETHINYL ESTRADIOL→DESOGESTREL AND ETHINYL ESTRADIOL vs LEVONORGESTREL AND ETHINYL ESTRADIOL→ETONOGESTREL AND ETHINYL ESTRADIOL vs LEVONORGESTREL AND ETHINYL ESTRADIOL→LEVONORGESTREL AND ETHINYL ESTRADIOL vs LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS→ESTRADIOL AND PROGESTERONE vs LEVONORGESTREL AND ETHINYL ESTRADIOL→

Loading comparison data...

LEVONORGESTREL AND ETHINYL ESTRADIOL vs TESTOSTERONE

Compare LEVONORGESTREL AND ETHINYL ESTRADIOL (Hormone) and TESTOSTERONE (Testopel) — clinical data, side effects, and patient experiences.

LEVONORGESTREL AND ETHINYL ESTRADIOL

· Hormone

How it works

12.1 Mechanism of Action COCs prevent pregnancy primarily by suppressing ovulation.

Approved for

a progestin

and ethinyl estradiol

an estrogen

indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )

OralTablet

TESTOSTERONE

Testopel · Hormone

How it works

Other agent

Approved for

bilateral torsion

orchitis

vanishing testes syndrome

or orchiectomy. b. Hypogonadotropic hypogonadism (congenital or acquired) - gonadotropic LHRH deficiency

SubcutaneousTablet

Quick Comparison

LEVONORGESTREL AND ETHINYL ESTRADIOLTESTOSTERONE

Drug Class

Hormone

Route

Oral

Subcutaneous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

LEVONORGESTREL AND ETHINYL ESTRADIOL

Nausea

0.1-1%

Abdominal Pain

0.1-1%

Drug Not Working

0.1-1%

Headache

0.1-1%

TESTOSTERONE

Drug Not Working

>10%

Fatigue

1-10%

Anxiety

1-10%

Weakness

1-10%

Headache

0.1-1%

Nausea

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

LEVONORGESTREL AND ETHINYL ESTRADIOL

5 WARNINGS AND PRECAUTIONS Vascular risks: Stop if a thrombotic or thromboembolic event occurs
Consider cardiovascular risk factors before initiating in all females, particularly those over 35 years
If feasible, stop Iclevia at least 4 weeks before and through 2 weeks after major surgery or other surgeries known to have an elevated risk of thromboembolism
The risk of postpartum thromboembolism decreases after the third postpartum week, whereas the likelihood of ovulation increases after the third postpartum week

TESTOSTERONE

WARNINGS In patients with breast cancer, androgen therapy may cause hypercalcemia by stimulating osteolysis
Peliosis hepatis can be a life-threatening or fatal complication
Men treated with androgens may be at an increased risk for the development of prostatic hypertrophy and prostatic carcinoma
To date, epidemiologic studies and randomized controlled trials have been inconclusive for determining the risk of major adverse cardiovascular events (MACE), such as non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death, with the use of testosterone compared to non-use

Clinical Trial Data

No head-to-head clinical studies found for LEVONORGESTREL AND ETHINYL ESTRADIOL vs TESTOSTERONE.

LEVONORGESTREL AND ETHINYL ESTRADIOL vs TESTOSTERONE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.